| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2013 | US8357718 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/22/2013 | US8357717 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity |
| 01/22/2013 | US8357716 Pyrazole derivatives used as CCR4 receptor antagonists |
| 01/22/2013 | US8357715 Hetero-substituted acetanilide derivatives as analgesic agents |
| 01/22/2013 | US8357714 Compositions and methods for non-surgical treatment of ptosis |
| 01/22/2013 | US8357713 Compounds and compositions and methods of use |
| 01/22/2013 | US8357712 4,5-dihydro-oxazol-2yl derivatives |
| 01/22/2013 | US8357711 Heterocyclic sulfonamides as inhibitors of ion channels |
| 01/22/2013 | US8357710 Bicyclic angiotensin II agonists |
| 01/22/2013 | US8357709 2,4-disubstituted pyrrolidine orexin receptor antagonists |
| 01/22/2013 | US8357708 Macrocyclic compounds and methods of treatment |
| 01/22/2013 | US8357707 2-carboxamide cycloamino ureas |
| 01/22/2013 | US8357706 Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis |
| 01/22/2013 | US8357705 Substituted cyclohexyldiamines |
| 01/22/2013 | US8357704 Fused heterocyclic compounds as inhibitors of potassium channel function |
| 01/22/2013 | US8357703 Pyridines |
| 01/22/2013 | US8357702 Bicyclic derivatives as modulators of voltage gated ion channels |
| 01/22/2013 | US8357701 Galactokinase inhibitors |
| 01/22/2013 | US8357700 2,3-disubstituted piperidine orexin receptor antagonists |
| 01/22/2013 | US8357699 6-aminoisoquinoline compounds |
| 01/22/2013 | US8357698 Diacyl indazole derivatives as lipase and phospholipase inhibitors |
| 01/22/2013 | US8357696 Aerosolized fluoroquinolones and uses thereof |
| 01/22/2013 | US8357695 Hydrates of 2-chloro-5-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1-(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide |
| 01/22/2013 | US8357694 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds |
| 01/22/2013 | US8357693 Pharmacokinetically improved compounds |
| 01/22/2013 | US8357692 Methods of treatment of bone degenerative diseases |
| 01/22/2013 | US8357691 Synthesis and anti-proliferative effect of benzimidazole derivatives |
| 01/22/2013 | US8357690 Methods of treatment using combination therapy |
| 01/22/2013 | US8357689 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus |
| 01/22/2013 | US8357688 Substituted imidazo[1,5-a]quinoxalin-4(5H)-ones as PDE9 inhibitors |
| 01/22/2013 | US8357687 Macrocyclic indole derivatives useful as hepatitis C virus inhibitors |
| 01/22/2013 | US8357686 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 01/22/2013 | US8357685 Substituted diketopiperazines and their use as oxytocin antagonists |
| 01/22/2013 | US8357684 Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase |
| 01/22/2013 | US8357683 Compounds for enzyme inhibition |
| 01/22/2013 | US8357682 Gamma secretase modulators |
| 01/22/2013 | US8357680 Remedy for diabetes |
| 01/22/2013 | US8357679 Hexafluoroisopropanol derivatives |
| 01/22/2013 | US8357678 Chair ruthenium complexes and their use as anticancer agents |
| 01/22/2013 | US8357677 Methods of treating hypertriglyceridemia |
| 01/22/2013 | US8357676 Ansamycin formulations and methods of use thereof |
| 01/22/2013 | US8357675 17-alpha-substituted derivatives of estradiol with wound-healing activity |
| 01/22/2013 | US8357674 Analogues of cilostazol |
| 01/22/2013 | US8357673 4-arylazo-3,5-diamino-pyrazole compounds and use thereof |
| 01/22/2013 | US8357672 Cell lysis reagent for isolation of RNA |
| 01/22/2013 | US8357671 High affinity Siglec ligands |
| 01/22/2013 | US8357670 Oligomeric compounds for the modulation of HIF-1A expression |
| 01/22/2013 | US8357669 Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D |
| 01/22/2013 | US8357405 Nut skin products and methods of use thereof |
| 01/22/2013 | US8357401 Stable formulations for lyophilizing therapeutic particles |
| 01/22/2013 | US8357399 Tamper-resistant oral opioid agonist formulations |
| 01/22/2013 | US8357398 Benzonatate compositions and methods of use |
| 01/22/2013 | US8357393 drug and a dermal penetration enhancer that form an amorphous deposit upon evaporation of the volatile carrier to control the extent and/or profile of transdermal release of a drug |
| 01/22/2013 | US8357392 Dry antiseptic wipes comprising an amphoteric surfactant |
| 01/22/2013 | US8357386 Drug eluting coatings for medical implants and methods of use |
| 01/22/2013 | US8357385 Combination therapy for the treatment of bacterial infections |
| 01/22/2013 | US8357380 Coenzyme Q10-containing composition |
| 01/22/2013 | US8357374 Conjugates of synthetic TLR agonists and uses therefor |
| 01/22/2013 | US8357368 Methods of treating pancreatic or liver cancer using hedgehog antagonists |
| 01/22/2013 | US8357361 Bioabsorbable surgical composition |
| 01/22/2013 | US8357359 Malodor control composition having an acid catalyst and methods thereof |
| 01/22/2013 | CA2756104C Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action |
| 01/22/2013 | CA2744515C Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic |
| 01/22/2013 | CA2725810C Tetomilast polymorphs |
| 01/22/2013 | CA2699733C 6,11-bridged biaryl macrolides |
| 01/22/2013 | CA2695372C Methods for treating dependence |
| 01/22/2013 | CA2685214C Improved controlled release oral dosage form |
| 01/22/2013 | CA2683946C Triazole derivatives which are smo antagonists |
| 01/22/2013 | CA2683522C 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 01/22/2013 | CA2670773C 6-alkoxyalkyl estradiol derivatives and methods of use |
| 01/22/2013 | CA2667397C Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment (mci), and improvement of cognitive function |
| 01/22/2013 | CA2667031C Hcv ns3 protease inhibitors |
| 01/22/2013 | CA2653939C Immunostimulatory oligonucleotides and use thereof in pharmaceuticals |
| 01/22/2013 | CA2650932C Substituted spirocyclic cgrp receptor antagonists |
| 01/22/2013 | CA2648751C Use of aminapthone for the preparation of a medicament for treating arteriopathies |
| 01/22/2013 | CA2646460C Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites |
| 01/22/2013 | CA2602610C Benzimidazole compound |
| 01/22/2013 | CA2599315C Composition for reducing the exudation of serum proteins |
| 01/22/2013 | CA2588979C 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 01/22/2013 | CA2583237C Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 01/22/2013 | CA2580147C Composition for prevention or alleviation of pigmentation |
| 01/22/2013 | CA2576640C Bimetal complexes and methods of making them |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/22/2013 | CA2565051C Novel use of peptide compounds for treating dyskinesia |
| 01/22/2013 | CA2560648C 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors |
| 01/22/2013 | CA2560595C Multi-vitamin and mineral nutritional supplements |
| 01/22/2013 | CA2560293C Substituted 1,4,8-triazaspiro[4.5]decan-2-on compounds |
| 01/22/2013 | CA2558783C Oral morphine multiparticulate formulation |
| 01/22/2013 | CA2550053C Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 01/22/2013 | CA2546672C Use of c-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders |
| 01/22/2013 | CA2537812C C-met modulators and method of use |
| 01/22/2013 | CA2527691C Condensed ring compound |
| 01/22/2013 | CA2515777C Biphenyl derivatives |
| 01/22/2013 | CA2506798C Compositions and systems for the regulation of genes |
| 01/22/2013 | CA2505298C Methods and compositions for applying pharmacologic agents to the ear |
| 01/22/2013 | CA2499677C Classes of compounds that interact with gpcrs |
| 01/22/2013 | CA2484334C High-quality lipids and methods for producing by enzymatic liberation from biomass |
| 01/22/2013 | CA2452644C Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 01/22/2013 | CA2448607C Colloidal metal compositions and methods |
| 01/22/2013 | CA2441970C Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |